Clinical Trials
37 trialsChemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Memorial Sloan Kettering Cancer Center
RECOGNISE
University of Turin, Italy
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
The Netherlands Cancer Institute
AFACET
The Netherlands Cancer Institute
Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer
University of California, Davis
Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer
University of Alabama at Birmingham
ACE-Lung
Intergroupe Francophone de Cancerologie Thoracique
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Swiss Cancer Institute
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
Intergroupe Francophone de Cancerologie Thoracique
Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Fuda Cancer Hospital, Guangzhou
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Masonic Cancer Center, University of Minnesota
Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Institut de Cancérologie de la Loire
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
UNC Lineberger Comprehensive Cancer Center
Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
University of California, Davis
MesoMab
University Hospital, Ghent
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
University of Pittsburgh
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Hoosier Cancer Research Network
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
Stanford University
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib
Memorial Sloan Kettering Cancer Center
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)
Medical University of Vienna
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
University of Chicago
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
Accelerated Community Oncology Research Network
TYKERB-ITUX 1
Georgetown University
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
SCRI Development Innovations, LLC
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
Massachusetts General Hospital
CALC-1
National Cancer Institute, Naples
Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Heidelberg University
Phase I Cetuximab and Concurrent Radio-chemotherapy
Maastricht Radiation Oncology
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
Fox Chase Cancer Center
TEXO
Medical University Innsbruck
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
Dana-Farber Cancer Institute
Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Veeda Oncology
Coimbra
Grupo Portugues de Estudo do Cancro do Pulmao